127 related articles for article (PubMed ID: 19807742)
1. Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas.
Nasti S; Pastorino L; Bruno W; Gargiulo S; Battistuzzi L; Zavattaro E; Leigheb G; De Francesco V; Tulli A; Mari F; Scarrà GB; Ghiorzo P
Clin Genet; 2009 Nov; 76(5):481-5. PubMed ID: 19807742
[No Abstract] [Full Text] [Related]
2. Inherited cylindromas: lessons from a rare tumour.
Rajan N; Ashworth A
Lancet Oncol; 2015 Sep; 16(9):e460-e469. PubMed ID: 26370355
[TBL] [Abstract][Full Text] [Related]
3. Blaschkoid distribution of cylindromas in a germline CYLD mutation carrier.
Furuichi M; Makino T; Yamakoshi T; Matsui K; Shimizu T
Br J Dermatol; 2012 Jun; 166(6):1376-8. PubMed ID: 22296260
[No Abstract] [Full Text] [Related]
4. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.
Nagy N; Rajan N; Farkas K; Kinyó A; Kemény L; Széll M
Acta Derm Venereol; 2013 Nov; 93(6):743-5. PubMed ID: 23584127
[No Abstract] [Full Text] [Related]
5. Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells.
Rajan N; Andersson MK; Sinclair N; Fehr A; Hodgson K; Lord CJ; Kazakov DV; Vanecek T; Ashworth A; Stenman G
J Pathol; 2016 Jun; 239(2):197-205. PubMed ID: 26969893
[TBL] [Abstract][Full Text] [Related]
6. Tracking tumor kinetics in patients with germline CYLD mutations.
Brown S; Worthy SA; Langtry JAA; Rajan N
J Am Acad Dermatol; 2018 Nov; 79(5):949-951. PubMed ID: 29660420
[No Abstract] [Full Text] [Related]
7. Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma.
Bülau JE; Kreipe HH; Jessen E; von Hardenberg S; Auber B; Grohé C; Leo F
Clin Lung Cancer; 2021 Nov; 22(6):e795-e798. PubMed ID: 33896728
[No Abstract] [Full Text] [Related]
8. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
[TBL] [Abstract][Full Text] [Related]
9. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
[TBL] [Abstract][Full Text] [Related]
10. Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction.
Rajan N; Langtry JA; Ashworth A; Roberts C; Chapman P; Burn J; Trainer AH
Arch Dermatol; 2009 Nov; 145(11):1277-84. PubMed ID: 19917957
[TBL] [Abstract][Full Text] [Related]
11. CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma.
Williams EA; Montesion M; Sharaf R; Corines J; Patel PJ; Gillespie BJ; Pavlick DC; Sokol ES; Alexander BM; Williams KJ; Elvin JA; Ross JS; Ramkissoon SH; Hemmerich AC; Tse JY; Mochel MC
Mod Pathol; 2020 Dec; 33(12):2614-2625. PubMed ID: 32461623
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.
Lian F; Cockerell CJ
Adv Dermatol; 2005; 21():217-34. PubMed ID: 16350444
[No Abstract] [Full Text] [Related]
13. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology.
Kazakov DV; Thoma-Uszynski S; Vanecek T; Kacerovska D; Grossmann P; Michal M
Am J Dermatopathol; 2009 Oct; 31(7):664-73. PubMed ID: 19668078
[TBL] [Abstract][Full Text] [Related]
14. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290
[TBL] [Abstract][Full Text] [Related]
15. PLAG1 and CYLD do not play a role in the tumorigenesis of adenoid cystic carcinoma.
Daa T; Nakamura I; Yada N; Arakane S; Nishida H; Kashima K; Suzuki M; Yokoyama S
Mol Med Rep; 2013 Apr; 7(4):1086-90. PubMed ID: 23404581
[TBL] [Abstract][Full Text] [Related]
16. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.
Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N
J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270
[TBL] [Abstract][Full Text] [Related]
17. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
18. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
[TBL] [Abstract][Full Text] [Related]
19. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
[TBL] [Abstract][Full Text] [Related]
20. Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control.
Massoumi R; Paus R
Bioessays; 2007 Dec; 29(12):1203-14. PubMed ID: 18008375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]